Literature DB >> 26330156

Impact of Volume Guarantee on High-Frequency Oscillatory Ventilation in Preterm Infants: A Randomized Crossover Clinical Trial.

Burcin Iscan1, Nuray Duman, Funda Tuzun, Abdullah Kumral, Hasan Ozkan.   

Abstract

BACKGROUND: High-frequency oscillatory ventilation (HFOV) with volume guarantee (VG) is a new ventilation mode that allows the clinician to set a mean tidal volume to be delivered.
OBJECTIVE: This study aimed to investigate whether HFOV with a VG option may result in constant tidal volume delivery and less fluctuant CO2 levels compared to HFOV alone in premature infants with respiratory distress syndrome (RDS).
METHODS: Inborn infants at less than 32 weeks of gestation with RDS requiring invasive mechanical ventilation were eligible. Patients were randomized to receive HFOV + VG or HFOV alone as the initial ventilator mode and then crossed over to the other mode. HFOV was performed with 'optimal lung volume strategy' during both of the periods.
RESULTS: Twenty infants were evaluated. The mean high-frequency tidal volume (VThf) and CO2 diffusion coefficient (DCO2) were significantly higher in the HFOV + VG mode than HFOV alone. HFOV + VG maintains VThf within the target range more consistently than HFOV. The incidences of hypocarbia and hypercarbia were lower in HFOV with VG than HFOV alone.
CONCLUSION: This is the first prospective, randomized, short-term crossover clinical study that compared HFOV with and without VG in infants with acute RDS. Because of the lower VThf fluctuation and lower incidences of out-of-target PCO2 levels, HFOV combined with VG seems to be feasible for preterm infants. However, the results should be interpreted with caution due to the small sample size and short-term crossover design of the study.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26330156     DOI: 10.1159/000437204

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  7 in total

Review 1.  High-frequency ventilation in preterm infants and neonates.

Authors:  Benjamin W Ackermann; Daniel Klotz; Roland Hentschel; Ulrich H Thome; Anton H van Kaam
Journal:  Pediatr Res       Date:  2022-02-08       Impact factor: 3.756

2.  Hemodynamic effects of high frequency oscillatory ventilation with volume guarantee in a piglet model of respiratory distress syndrome.

Authors:  Jagmeet Bhogal; Anne Lee Solevåg; Megan O'Reilly; Tze-Fun Lee; Chloe Joynt; Lisa K Hornberger; Georg M Schmölzer; Po-Yin Cheung
Journal:  PLoS One       Date:  2021-02-16       Impact factor: 3.240

3.  Respiratory and Gastrointestinal Management of an Infant with a Birth Weight of 258 Grams.

Authors:  Ryo Itoshima; Arata Oda; Ryo Ogawa; Toshimitsu Yanagisawa; Takehiko Hiroma; Tomohiko Nakamura
Journal:  AJP Rep       Date:  2021-10-25

4.  Effects of High-Frequency Oscillatory Ventilation With Volume Guarantee During Surfactant Treatment in Extremely Low Gestational Age Newborns With Respiratory Distress Syndrome: An Observational Study.

Authors:  Milena Tana; Angela Paladini; Chiara Tirone; Claudia Aurilia; Alessandra Lio; Anthea Bottoni; Simonetta Costa; Eloisa Tiberi; Roberta Pastorino; Giovanni Vento
Journal:  Front Pediatr       Date:  2022-03-03       Impact factor: 3.418

5.  Effective Tidal Volume for Normocapnia in Very-Low-Birth-Weight Infants Using High-Frequency Oscillatory Ventilation.

Authors:  Seul Mi Lee; Ran Namgung; Ho Sun Eun; Soon Min Lee; Min Soo Park; Kook In Park
Journal:  Yonsei Med J       Date:  2018-01       Impact factor: 2.759

6.  Effect of a new respiratory care bundle on bronchopulmonary dysplasia in preterm neonates.

Authors:  Cristina Ramos-Navarro; Noelia González-Pacheco; Ana Rodríguez-Sánchez de la Blanca; Manuel Sánchez-Luna
Journal:  Eur J Pediatr       Date:  2020-06-02       Impact factor: 3.183

7.  Volume Guarantee High-Frequency Oscillatory Ventilation in Preterm Infants With RDS: Tidal Volume and DCO2 Levels for Optimal Ventilation Using Open-Lung Strategies.

Authors:  Funda Tuzun; Burak Deliloglu; Merve Meryem Cengiz; Burcin Iscan; Nuray Duman; Hasan Ozkan
Journal:  Front Pediatr       Date:  2020-03-24       Impact factor: 3.418

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.